Asserter profile

COLE HAAN LLC, NEW HAMPSHIRE

operating company0 patents now1 ever0 cases filed during tenure2 connections

PTAB exposure

1of this entity’s patents have been challenged at PTAB (1 total proceeding).

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Ncole_haan_new_hampshire["COLE HAAN LLC, NEW HAMPSHIRE"]
    Nboys_jack_bono_ann_verfl_mattias_shepherd_aubert["BOYS, JACK; BONO, ANN; VERFL, MATTIAS;…"]
    Nalter_domus_us_as_collateral_agent["ALTER DOMUS (US) LLC, AS COLLATERAL AGE…"]
    Ncole_haan["COLE HAAN LLC"]
    Nboys_jack_bono_ann_verfl_mattias_shepherd_aubert -->|"2019 · Assignment · 11041262"| Ncole_haan_new_hampshire
    Nalter_domus_us_as_collateral_agent -->|"2023 · Release by Secured Party · 11041262"| Ncole_haan_new_hampshire
    Ncole_haan -->|"2020 · Patent Security Agreement · 10443163"| Nalter_domus_us_as_collateral_agent
    Nalter_domus_us_as_collateral_agent -->|"2023 · Release By Secured Party · 10443163"| Ncole_haan
    Ncole_haan -->|"2020 · Security Agreement · 10327511"| Nalter_domus_us_as_collateral_agent
    Nalter_domus_us_as_collateral_agent -->|"2023 · Release · 10327511"| Ncole_haan
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Ncole_haan_new_hampshire focal
    class Nalter_domus_us_as_collateral_agent operating
    class Ncole_haan operating

Patents previously held (1)

Connected entities (2)

Correspondent attorneys (2)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.